Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney Disease.
Tatsufumi OkaYusuke SakaguchiKoki HattoriYuta AsahinaSachio KajimotoYohei DoiJun-Ya KaimoriYoshitaka IsakaPublished in: Hypertension (Dallas, Tex. : 1979) (2022)
MRA users showed a better renal prognosis across various chronic kidney disease subgroups in a real-world chronic kidney disease population.